Physician profile
Lev Blekher
NPI 1578231353
$1,620.98
in general payments reported to CMS, 2019-2025
13 companies · $194 in 2025
The $194 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $46.57 · 2022: $421 · 2023: $773 · 2024: $187 · 2025: $194.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,153.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $390.15 | 2022-2023 | Senza |
| Stryker Corporation | $285.49 | 2022-2025 | Ortholoc 3di |
| Smith+Nephew, INC. | $253.56 | 2022-2025 | Collagenase Santyl, Stravix Pl |
| Paratek Pharmaceuticals, INC. | $188.66 | 2023-2024 | Nuzyra |
| Biotronik Nro, INC. | $131.89 | 2025 | Prospera |
| Averitas Pharma INC. | $115.92 | 2023 | Qutenza |
| Convatec INC. | $69.53 | 2023 | |
| Orthofix Medical, INC. | $61.07 | 2023-2024 | Truelok, Physio-Stim |
| Zimmer Biomet Holdings, INC. | $46.57 | 2021 | |
| Ibsa Pharma INC. | $24.16 | 2023 | Tirosint, Licart |
| Kci USA, INC. | $20.68 | 2022 | |
| Integra Lifesciences Corporation | $20.57 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Acera Surgical, INC. | $12.73 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lev Blekher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.